Soo-Yun Lee,1 Jung-Ryul Kim,2,3 Jin Ah Jung,4 Wooseong Huh,2,5 Mi Young Bahng,6 Jae-Wook Ko1,2 1Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; 2Department of Clinical Pharmacology and ...
Lee SY +5 more
doaj
A PROSPECTIVE STUDY TO ANALYSE THE SIDE EFFECTS OF OLMESARTAN MEDOXOMIL AND ENALAPRIL IN HYPERTENSIVE SUBJECTS [PDF]
Objective: The present study was aimed to analyze the side effects of olmesartan medoxomil and enalapril in hypertensive subjects.Methods: The study consisted of newly diagnosed hypertension categorized according to 7th report of Joint National ...
Singh, Parminderpal, Kiranjit, Kiranjit
core
EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
Endothelial dysfunction is the common link between cardiovascular disease risk factors and the earliest event in the cascade of incidents that results in target organ damage.
C. Ferrario
doaj
Olmesartan-associated enteropathy presenting as severe malnutrition. [PDF]
Mpanda A, Sylla M, Young ED.
europepmc +1 more source
Drug-Specific Associations of Angiotensin Receptor Blockers With Parkinson's Disease Risk in a Multicenter Electronic Health Record Cohort. [PDF]
Tran K +8 more
europepmc +1 more source
Supplementary Material for: Severe hepatitis complicating olmesartan enteropathy
Introduction: Olmesartan, an angiotensin II receptor antagonist, is associated with an uncommon complication of enteropathy that presents insidiously, usually months to years after initial commencement of anti-hypertensive therapy which can be dose ...
Tabatabai S. (18306649) +5 more
core +1 more source
A Thermoresponsive In Situ Salified Self-Nanoemulsifying Drug Delivery System of Olmesartan Medoxomil: Overcoming Leakage and Drug Trapping Limitations. [PDF]
Sherif AY, Altamimi MA, Elzayat EM.
europepmc +1 more source
Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators. [PDF]
Dasan J +4 more
europepmc +1 more source
Disarming Pseudomonas aeruginosa: repurposing vardenafil, valsartan, and olmesartan as anti-virulence and antibiofilm agents. [PDF]
Mahfouz AA +3 more
europepmc +1 more source
Blood pressure lowering efficacy of sacubitril/allisartan versus olmesartan in elderly Chinese hypertensive patients. [PDF]
Zhang W +13 more
europepmc +1 more source

